{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:18:38Z","timestamp":1788963518375,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01075-z","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:05:05Z","timestamp":1782378305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating machine learning with histopathological, immunohistochemical, and PET parameters in the study of invasive breast carcinoma, no special type"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8985-463X","authenticated-orcid":false,"given":"Berkay","family":"\u00c7a\u011fda\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2264-5446","authenticated-orcid":false,"given":"H\u00fcseyin","family":"\u015ean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5358-3444","authenticated-orcid":false,"given":"Kardelen","family":"\u00c7a\u011fda\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0120-4817","authenticated-orcid":false,"given":"Ahmet","family":"K\u0131l\u0131\u00e7aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1478-5294","authenticated-orcid":false,"given":"Nedim C. M.","family":"G\u00fclald\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"1075_CR1","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"MEH Hammond","year":"2010","unstructured":"Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology\/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. J Clin Oncol. 2010;28:2784\u201395. https:\/\/doi.org\/10.1200\/JCO.2009.25.6529.","journal-title":"J Clin Oncol"},{"key":"1075_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00259-010-1640-9","volume":"38","author":"D Groheux","year":"2011","unstructured":"Groheux D, Giacchetti S, Moretti J-L, Porcher R, Espi\u00e9 M, Lehmann-Che J, et al. Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer. Eur J Nucl Med Mol Imaging. 2011;38:426\u201335. https:\/\/doi.org\/10.1007\/s00259-010-1640-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1075_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10549-011-1767-9","volume":"131","author":"BB Koolen","year":"2012","unstructured":"Koolen BB, Vrancken Peeters M-JTFD, Aukema TS, Vogel WV, Oldenburg HSA, Van Der Hage JA, et al. 18F-FDG PET\/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques. Breast Cancer Res Treat. 2012;131:117\u201326. https:\/\/doi.org\/10.1007\/s10549-011-1767-9.","journal-title":"Breast Cancer Res Treat"},{"key":"1075_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/bjc.1957.43","volume":"11","author":"HJG Bloom","year":"1957","unstructured":"Bloom HJG, Richardson WW. Histological Grading and Prognosis in Breast Cancer: A Study of 1409 Cases of which 359 have been Followed for 15 Years. Br J Cancer. 1957;11:359\u201377.","journal-title":"Br J Cancer"},{"key":"1075_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/0971-5851.180141","volume":"37","author":"P Arul","year":"2016","unstructured":"Arul P, Masilamani S. Comparative evaluation of various cytomorphological grading systems in breast carcinoma. Indian J Med Paediatr Oncol. 2016;37:79\u201384. https:\/\/doi.org\/10.4103\/0971-5851.180141.","journal-title":"Indian J Med Paediatr Oncol"},{"key":"1075_CR6","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","volume":"11","author":"R Rouzier","year":"2005","unstructured":"Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy. Clin Cancer Res. 2005;11:5678\u201385.","journal-title":"Clin Cancer Res"},{"key":"1075_CR7","doi-asserted-by":"publisher","unstructured":"Kluyver Thomas R-K, Benjamin, P\u00e9rez Fernando G, Brian B, Matthias F, Jonathan, et al. Jupyter Notebooks\u2014a publishing format for reproducible computational workflows. Positioning and Power in Academic Publishing: Players, Agents and Agendas [Internet]. IOS; 2016. pp. 87\u201390. [cited 2025 June 30]. https:\/\/doi.org\/10.3233\/978-1-61499-649-1-87.","DOI":"10.3233\/978-1-61499-649-1-87"},{"key":"1075_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/bjs.6459","volume":"96","author":"A Gil-Rendo","year":"2009","unstructured":"Gil-Rendo A, Mart\u00ednez-Regueira F, Zornoza G, Garc\u00eda-Velloso MJ, Beorlegui C, Rodriguez-Spiteri N. Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer. BJS. 2009;96:166\u201370. https:\/\/doi.org\/10.1002\/bjs.6459.","journal-title":"BJS"},{"key":"1075_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/MNM.0000000000000694","volume":"38","author":"D Has \u015eim\u015fek","year":"2017","unstructured":"Has \u015eim\u015fek D, \u015eanli Y, K\u00fclle CB, Karanlik H, Kili\u00e7 B, Kuyumcu S, et al. Correlation of 18F-FDG PET\/CT with pathological features and survival in primary breast cancer. Nucl Med Commun. 2017;38:694\u2013700. https:\/\/doi.org\/10.1097\/MNM.0000000000000694.","journal-title":"Nucl Med Commun"},{"key":"1075_CR10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1177\/000313480707301116","volume":"73","author":"N Ikenaga","year":"2007","unstructured":"Ikenaga N, Otomo N, Toyofuku A, Ueda Y, Toyoda K, Hayashi T, et al. Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors. Am Surg. 2007;73:1151\u20137.","journal-title":"Am Surg"},{"key":"1075_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12149-021-01688-3","volume":"36","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wang Z, Yin G, Sui C, Liu Z, Li X, et al. Prediction of HER2 expression in breast cancer by combining PET\/CT radiomic analysis and machine learning. Ann Nucl Med. 2022;36:172\u201382. https:\/\/doi.org\/10.1007\/s12149-021-01688-3.","journal-title":"Ann Nucl Med"},{"key":"1075_CR12","doi-asserted-by":"crossref","unstructured":"Groheux D, Ferrer L, Vargas J, Martineau A, Borgel A, Teixeira L. FDG-PET\/CT and multimodal machine learning model prediction of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer. Cancers. 2025;17.","DOI":"10.3390\/cancers17071249"},{"key":"1075_CR13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s11307-023-01823-8","volume":"25","author":"K Kawaji","year":"2023","unstructured":"Kawaji K, Nakajo M, Shinden Y, Jinguji M, Tani A, Hirahara D. Application of Machine Learning Analyses Using Clinical and [18F]-FDG-PET\/CT Radiomic Characteristics to Predict Recurrence in Patients with Breast Cancer. Mol Imaging Biol. 2023;25:923\u201334.","journal-title":"Mol Imaging Biol"},{"key":"1075_CR14","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s00259-015-3110-x","volume":"42","author":"D Groheux","year":"2015","unstructured":"Groheux D, Majdoub M, Tixier F, Le Rest CC, Martineau A, Merlet P, et al. Do clinical, histological or immunohistochemical primary tumour characteristics translate into different 18F-FDG PET\/CT volumetric and heterogeneity features in stage II\/III breast cancer? Eur J Nucl Med Mol Imaging. 2015;42:1682\u201391. https:\/\/doi.org\/10.1007\/s00259-015-3110-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1075_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1967\/s002449911051","volume":"22","author":"M Ravina","year":"2019","unstructured":"Ravina M, Saboury B, Chauhan MS, Jacob MJ, Pandit AG, Sanchety N, et al. Utility of 18 F-FDG PET\/CT in pre-surgical risk stratification of patients with breast cancer. Hell J Nucl Med. 2019;22:165\u201371. https:\/\/doi.org\/10.1967\/s002449911051.","journal-title":"Hell J Nucl Med"},{"key":"1075_CR16","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MNM.0000000000000856","volume":"39","author":"E Arslan","year":"2018","unstructured":"Arslan E, \u00c7ermik TF, Trabulus FDC, Talu ECK, Ba\u015faran \u015e. Role of 18F-FDG PET\/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer. Nuc Med Commun. 2018;39:680\u201390. https:\/\/doi.org\/10.1097\/MNM.0000000000000856.","journal-title":"Nuc Med Commun"},{"key":"1075_CR17","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1097\/MNM.0b013e3283658369","volume":"34","author":"O Ekmekcioglu","year":"2013","unstructured":"Ekmekcioglu O, Aliyev A, Yilmaz S, Arslan E, Kaya R, Kocael P, et al. Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma. Nucl Med Commun. 2013;34:1055\u201367. https:\/\/doi.org\/10.1097\/MNM.0b013e3283658369.","journal-title":"Nucl Med Commun"},{"key":"1075_CR18","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s10147-010-0120-3","volume":"15","author":"P Heudel","year":"2010","unstructured":"Heudel P, Cimarelli S, Montella A, Bouteille C, Mognetti T. Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors. Int J Clin Oncol. 2010;15:588\u201393.","journal-title":"Int J Clin Oncol"},{"key":"1075_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12149-011-0556-1","volume":"26","author":"BS Kim","year":"2012","unstructured":"Kim BS, Sung SH. Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer. Ann Nucl Med. 2012;26:175\u201383.","journal-title":"Ann Nucl Med"},{"key":"1075_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejrad.2019.02.005","volume":"113","author":"M Grapin","year":"2019","unstructured":"Grapin M, Coutant C, Riedinger J-M, Ladoire S, Brunotte F, Cochet A, et al. Combination of breast imaging parameters obtained from 18F-FDG PET and CT scan can improve the prediction of breast-conserving surgery after neoadjuvant chemotherapy in luminal\/HER2-negative breast cancer. Eur J Radiol. 2019;113:81\u20138. https:\/\/doi.org\/10.1016\/j.ejrad.2019.02.005.","journal-title":"Eur J Radiol"},{"key":"1075_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2214\/AJR.13.10841","volume":"202","author":"V Paidpally","year":"2014","unstructured":"Paidpally V, Mercier G, Shah BA, Senthamizhchelvan S, Subramaniam RM. Interreader Agreement and Variability of FDG PET Volumetric Parameters in Human Solid Tumors. Am J Roentgenol. 2014;202:406\u201312. https:\/\/doi.org\/10.2214\/AJR.13.10841.","journal-title":"Am J Roentgenol"},{"key":"1075_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11547-025-01958-4","volume":"130","author":"L Urso","year":"2025","unstructured":"Urso L, Manco L, Cittanti C, Adamantiadis S, Szilagyi KE, Scribano G, et al. 18F-FDG PET\/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Radiol med. 2025;130:543\u201354. https:\/\/doi.org\/10.1007\/s11547-025-01958-4.","journal-title":"Radiol med"},{"key":"1075_CR23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/cancers17071249","volume":"17","author":"D Groheux","year":"2025","unstructured":"Groheux D, Ferrer L, Vargas J, Martineau A, Borgel A, Teixeira L, et al. FDG-PET\/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers. 2025;17:1249. https:\/\/doi.org\/10.3390\/cancers17071249.","journal-title":"Cancers"},{"key":"1075_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s11307-023-01823-8","volume":"25","author":"K Kawaji","year":"2023","unstructured":"Kawaji K, Nakajo M, Shinden Y, Jinguji M, Tani A, Hirahara D, et al. Application of Machine Learning Analyses Using Clinical and [18F]-FDG-PET\/CT Radiomic Characteristics to Predict Recurrence in Patients with Breast Cancer. Mol Imaging Biol. 2023;25:923\u201334. https:\/\/doi.org\/10.1007\/s11307-023-01823-8.","journal-title":"Mol Imaging Biol"},{"key":"1075_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13550-023-01053-7","volume":"13","author":"X Zheng","year":"2023","unstructured":"Zheng X, Huang Y, Lin Y, Zhu T, Zou J, Wang S, et al. 18F-FDG PET\/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer. EJNMMI Res. 2023;13:105. https:\/\/doi.org\/10.1186\/s13550-023-01053-7.","journal-title":"EJNMMI Res"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01075-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:02:09Z","timestamp":1788962529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01075-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01075-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7049208\/v1","asserted-by":"object"}]},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Scientific and Ethical Review Board for Medical Research at our hospital (10 July 2024, TABED 2-24-343).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"122"}}